Opus Genetics, Inc. (Nasdaq: IRD) (“Opus Genetics” or the “Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® ...
Cytokinetics, Incorporated (Nasdaq: CYTK) today announced positive topline results from ACACIA-HCM (Assessment Comparing ...
UNC has officially opened a new office in Washington, D.C., which the university is dubbing "Carolina in the Capital." ...
The University of North Carolina at Chapel Hill has opened a new office in Washington, D.C., establishing an expanded ...
The new CI-Fortify initiative urges critical infrastructure operators to prepare for cyberattacks by ensuring they can ...
Trial Met Dual Primary Endpoints of KCCQ and Maximal Exercise Performance With Consistent Positive Findings Across Key ...
The Transportation Security Administration is offering money off a first-time five-year membership in its PreCheck program.
Stoke Therapeutics, Inc.: late-stage zorevunersen for SCN1A Dravet Syndrome with durable 3-year data, Phase 3 EMPEROR and ...
The House Committee on Oversight and Government Reform has held a markup and advanced nine bills aimed at protecting taxpayer ...
A discussion of the rapid integration of AI in the US insurance industry, the legal and ethical challenges arising from AI ...
How DesignAgency’s three founders have spent 28 years turning hospitality spaces into emotional experiences — and why the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results